Free Trial

MiMedx Group (MDXG) Competitors

MiMedx Group logo
$7.16 -0.03 (-0.42%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$7.16 0.00 (0.00%)
As of 08/1/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDXG vs. INSP, TMDX, NVST, PRCT, WRBY, LIVN, EYE, LMAT, LQDA, and CNMD

Should you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.

MiMedx Group vs. Its Competitors

Inspire Medical Systems (NYSE:INSP) and MiMedx Group (NASDAQ:MDXG) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Inspire Medical Systems currently has a consensus target price of $208.55, indicating a potential upside of 65.32%. MiMedx Group has a consensus target price of $12.00, indicating a potential upside of 67.60%. Given MiMedx Group's stronger consensus rating and higher probable upside, analysts clearly believe MiMedx Group is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 1.7% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, MiMedx Group had 9 more articles in the media than Inspire Medical Systems. MarketBeat recorded 17 mentions for MiMedx Group and 8 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.31 beat MiMedx Group's score of 0.99 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiMedx Group
5 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MiMedx Group has a net margin of 8.84% compared to Inspire Medical Systems' net margin of 7.92%. MiMedx Group's return on equity of 23.03% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems7.92% 10.00% 8.68%
MiMedx Group 8.84%23.03%17.09%

Inspire Medical Systems has higher revenue and earnings than MiMedx Group. MiMedx Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$802.80M4.63$53.51M$2.1758.13
MiMedx Group$348.88M3.04$42.42M$0.2134.10

Inspire Medical Systems has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.79, suggesting that its share price is 79% more volatile than the S&P 500.

Summary

Inspire Medical Systems beats MiMedx Group on 9 of the 16 factors compared between the two stocks.

Get MiMedx Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXG vs. The Competition

MetricMiMedx GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.06B$2.99B$5.48B$9.53B
Dividend YieldN/A2.43%4.73%4.09%
P/E Ratio34.1017.7428.8923.83
Price / Sales3.04178.71371.1466.13
Price / Cash21.7041.9535.4557.96
Price / Book4.908.508.265.54
Net Income$42.42M-$55.06M$3.25B$259.28M
7 Day Performance5.76%-3.99%-3.73%-4.67%
1 Month Performance14.93%9.58%4.28%4.37%
1 Year Performance10.84%6.70%25.85%17.90%

MiMedx Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDXG
MiMedx Group
3.097 of 5 stars
$7.16
-0.4%
$12.00
+67.6%
+7.2%$1.06B$348.88M34.10870Trending News
Earnings Report
Analyst Forecast
Analyst Revision
INSP
Inspire Medical Systems
4.7251 of 5 stars
$130.72
+1.4%
$208.55
+59.5%
-13.1%$3.80B$802.80M60.241,246Positive News
Upcoming Earnings
TMDX
TransMedics Group
2.4639 of 5 stars
$105.24
-2.7%
$129.88
+23.4%
-20.4%$3.66B$441.54M77.38210Trending News
Earnings Report
Analyst Forecast
NVST
Envista
3.5834 of 5 stars
$20.73
-0.3%
$20.23
-2.4%
+22.7%$3.53B$2.50B-3.1712,300Trending News
Earnings Report
Analyst Forecast
Analyst Revision
PRCT
PROCEPT BioRobotics
2.5317 of 5 stars
$54.08
-2.9%
$84.13
+55.6%
-19.4%$3.08B$224.50M-31.81430Upcoming Earnings
WRBY
Warby Parker
2.0734 of 5 stars
$24.10
-1.2%
$22.88
-5.1%
+48.9%$2.55B$771.32M-200.833,780News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
Short Interest ↑
Gap Down
LIVN
LivaNova
2.9711 of 5 stars
$43.46
-0.5%
$59.29
+36.4%
-14.9%$2.38B$1.25B-10.632,900News Coverage
Positive News
Upcoming Earnings
EYE
National Vision
2.8879 of 5 stars
$24.48
-2.2%
$23.00
-6.0%
+78.3%$1.98B$1.82B-74.1813,411Positive News
Upcoming Earnings
Analyst Forecast
Analyst Revision
LMAT
LeMaitre Vascular
2.9881 of 5 stars
$82.47
+0.0%
$97.83
+18.6%
-6.0%$1.86B$219.86M41.65490Upcoming Earnings
LQDA
Liquidia Technologies
3.3925 of 5 stars
$19.82
+1.1%
$26.89
+35.7%
+52.5%$1.68B$14M-12.5450News Coverage
Upcoming Earnings
CNMD
CONMED
4.4037 of 5 stars
$50.05
-1.8%
$62.20
+24.3%
-20.0%$1.58B$1.32B13.173,900News Coverage
Earnings Report
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:MDXG) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners